Research Topics
| S R GoldringSummaryAffiliation: Harvard University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Pathogenesis of bone erosions in rheumatoid arthritisS R Goldring
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA
Curr Opin Rheumatol 12:195-9. 2000..This paper reviews the cellular mechanisms and factors implicated in bone erosions in rheumatoid arthritis, and discusses the possible therapeutic strategies suggested by these findings...
Inflammatory mediators as essential elements in bone remodelingS R Goldring
Beth Israel Deaconess Medical Center, Harvard Medical School, New England Baptist Bone and Joint Institute Harvard Institutes of Medicine, Boston, MA, USA
Calcif Tissue Int 73:97-100. 2003..These observations have important implications with respect to the development of therapeutic strategies to prevent bone loss in inflammatory conditions...
Pathogenesis of bone and cartilage destruction in rheumatoid arthritisS R Goldring
Harvard Medical School, New England Baptist Bone and Joint Institute, Boston, MA, USA
Rheumatology (Oxford) 42:ii11-6. 2003....
Bone and joint destruction in rheumatoid arthritis: what is really happening?Steven R Goldring
Harvard Medical School, New England Baptist Bone and Joint Institute, Boston, Massachusetts 02215, USA
J Rheumatol Suppl 65:44-8. 2002..These observations suggest that osteoclasts mediate focal bone erosions in RA and that targeting of osteoclasts and osteoclast mediated bone resorption represents a rational approach to preventing or reducing focal bone loss in RA...
Pathogenesis of bone lesions in rheumatoid arthritisSteven R Goldring
Harvard Institutes of Medicine, Room 241, 4 Blackfan Circle, Boston, MA 02115, USA
Curr Rheumatol Rep 4:226-31. 2002....
Pathogenesis of bone erosions in rheumatoid arthritisSteven R Goldring
Beth Israel Deaconess Medical Center, Harvard Medical School, and New England Baptist Bone and Joint Institute, Harvard Institutes of Medicine, Boston, Massachusetts 02115, USA
Curr Opin Rheumatol 14:406-10. 2002..These findings provide a rational framework for developing targeted therapies that can specifically inhibit or slow the progressive focal bone destruction associated with the rheumatoid synovial lesion...
The role of cell-substrate interaction in regulating osteoclast activation: potential implications in targeting bone loss in rheumatoid arthritisK P McHugh
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
Ann Rheum Dis 69:i83-85. 2010....
Angiopoietin-1 is expressed in the synovium of patients with rheumatoid arthritis and is induced by tumour necrosis factor alphaE M Gravallese
Beth Israel Deaconess Medical Center, Department of Medicine, New England Baptist Bone and Joint Institute, Harvard Institutes of Medicine, 4 Blackfan Circle, Boston, MA 02115, USA
Ann Rheum Dis 62:100-7. 2003..CONCLUSIONS: Ang-1 mRNA and protein are expressed in the synovium of patients with RA, and are up regulated in synovial fibroblasts by TNF alpha. Ang-1 may therefore be an important regulator of angiogenesis in inflammatory arthritis...
Role of cell-matrix interactions in osteoclast differentiationK P McHugh
Department of Orthopaedics and Rheumatology, Beth Israel Deaconess Medical Center, New England Baptist Hospital, and New England Baptist Bone and Joint Institute, Harvard Medical School, Boston, MA, USA
Adv Exp Med Biol 602:107-11. 2007..They also share a common lineage..
The role of TNF-receptor family members and other TRAF-dependent receptors in bone resorptionE M Gravallese
Beth Israel Deaconess Medical Center, New England Baptist Bone and Joint Institute, Harvard Institutes of Medicine, Harvard Medical School, Boston, MA 02115, USA
Arthritis Res 3:6-12. 2001....
NFATc1 directly induces the human beta3 integrin gene in osteoclast differentiationT N Crotti
Beth Israel Deaconess Medical Center, Boston, MA 02115, USA
J Musculoskelet Neuronal Interact 5:335-7. 2005
TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritisA R Pettit
Beth Israel Deaconess Medical Center, New England Baptist Bone and Joint Institute, Harvard Institutes of Medicine, Boston, Massachusetts 02115, USA
Am J Pathol 159:1689-99. 2001..These results confirm the central role of osteoclasts in the pathogenesis of bone erosion in arthritis and demonstrate distinct mechanisms of cartilage destruction and bone erosion in this animal model of arthritis...
NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiationTania N Crotti
Beth Israel Deaconess Medical Center, Boston, MA 02115, USA
Gene 372:92-102. 2006..Together these results establish the beta3 gene as a direct target of NFATc1 in RANKL-dependent osteoclast formation...
Rheumatic diseases: the effects of inflammation on boneNicole C Walsh
Beth Israel Deaconess Medical Center, New England Baptist Bone and Joint Institute, Harvard Institutes of Medicine, Boston, MA 02115, USA
Immunol Rev 208:228-51. 2005..In this review, we provide an overview of the cell types, inflammatory mediators, and mechanisms that are implicated in bone loss and new bone formation in inflammatory joint diseases...
A novel promoter regulates calcitonin receptor gene expression in human osteoclastsZhenxin Shen
New England Baptist Bone and Joint Institute, Boston, MA 02120, USA
Biochim Biophys Acta 1769:659-67. 2007....
Bisphosphonates: environmental protection for the joint?Steven R Goldring
Arthritis Rheum 50:2044-7. 2004
Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivoRomain Dacquin
Department of Molecular and Human Genetics and Bone Disease Program of Texas, Baylor College of Medicine, One Baylor Plaza, Room S921, Houston, TX 77030, USA
J Cell Biol 164:509-14. 2004..Thus, amylin is a physiological regulator of bone resorption that acts through an unidentified receptor...
ESE-1 is a novel transcriptional mediator of angiopoietin-1 expression in the setting of inflammationCourtney Brown
Beth Israel Deaconess Medical Center, Department of Medicine, New England Baptist Bone and Joint Institute, Harvard Institutes of Medicine, 4 Blackfan Circle, Boston, MA 02115, USA
J Biol Chem 279:12794-803. 2004..Our results support a novel paradigm for the ETS factor ESE-1 as a transcriptional mediator of angiogenesis in the setting of inflammation...
PU.1 and NFATc1 mediate osteoclastic induction of the mouse beta3 integrin promoterTania N Crotti
The New England Baptist Bone and Joint Institute, Department of Rheumatology, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, Massachusetts 02115, USA
J Cell Physiol 215:636-44. 2008..1, are involved in regulation of beta(3) integrin expression during osteoclast differentiation and suggest that PU.1 confers specificity to the NFATc1 response to macrophage lineage cells...
Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1Franck Grall
New England Baptist Bone and Joint Institute, Beth Israel Deaconess Medical Center and Harvard Medical School, and Beth Israel Deaconess Medical Center Genomics Center, Boston, Massachusetts 02115, USA
Arthritis Rheum 48:1249-60. 2003..ESE-1 may play a role in mediating some effects of proinflammatory stimuli in cells at sites of inflammation...
The role of bone in osteoarthritis pathogenesisSteven R Goldring
The Hospital for Special Surgery, Weill Medical College of Cornell University, 535 East 70th Street, New York, NY 10021, USA
Rheum Dis Clin North Am 34:561-71. 2008..In addition, the relationship of these changes to the alterations in articular cartilage and the other tissues comprising the diarthrodial joint are reviewed...
Increase in expression of receptor activator of nuclear factor kappaB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritisErik Lubberts
University Medical Center Nijmegen, Nijmegen, The Netherlands
Arthritis Rheum 46:3055-64. 2002..This study was undertaken to identify in vivo the hitherto-unknown origin and localization of RANK-expressing osteoclast precursor cells at sites of bone erosion in arthritis...
Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synoviumWu-Shiun Hou
Mount Sinai School of Medicine, New York, New York 10029, USA
Arthritis Rheum 46:663-74. 2002..Cathepsin S expression in macrophage-like synoviocytes suggests dual activity in antigen presentation and matrix degradation in the inflamed synovia...
The role played by cell-substrate interactions in the pathogenesis of osteoclast-mediated peri-implant osteolysisZhenxin Shen
New England Baptist Bone and Joint Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
Arthritis Res Ther 8:R70. 2006..We speculate that, in addition to the role of cytokines and growth factors, the substrate with which these cells interact plays a critical role in their differential phenotypic and functional properties...
OsteoarthritisMary B Goldring
Laboratory for Cartilage Biology, Research Division, The Hospital for Special Surgery, Weill College of Medicine of Cornell University, New York 10021, USA
J Cell Physiol 213:626-34. 2007....
The role of adsorbed endotoxin in particle-induced stimulation of cytokine releaseDavid R Cho
Harvard Institutes of Medicine, Rheumatology Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA
J Orthop Res 20:704-13. 2002..Furthermore, the presence of particle-associated endotoxin at the bone-implant interface in vivo could markedly enhance the adverse biological activity of particulate wear debris...
Relationship between cartilage stiffness and dGEMRIC index: correlation and predictionMarta Baldassarri
New England Baptist Bone and Joint Institute, Boston, Massachusetts, USA
J Orthop Res 25:904-12. 2007..A generalized relationship was found to provide good correspondence across sources and regions. Use of the dGEMRIC index as a predictive measure of stiffness is possible, depending on the application's acceptable error...
Eating bone or adding it: the Wnt pathway decidesSteven R Goldring
Nat Med 13:133-4. 2007
Novel dexamethasone-HPMA copolymer conjugate and its potential application in treatment of rheumatoid arthritisDong Wang
Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68198 6025, USA
Arthritis Res Ther 9:R2. 2007..This newly developed drug delivery system provides a unique method for selective targeting of glucocorticoids to inflamed joints which may potentially reduce systemic side effects...
The Ets transcription factor ESE-1 mediates induction of the COX-2 gene by LPS in monocytesFranck T Grall
New England Baptist Bone and Joint Institute and BIDMC Genomics Center, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115, USA
FEBS J 272:1676-87. 2005....
Gene expression clustering using self-organizing maps: analysis of the macrophage response to particulate biomaterialsGrant E Garrigues
Biomaterials Laboratory, Massachusetts General Hospital, Harvard Medical School, GRJ 1115, 55 Fruit Street, Boston, MA 02114, USA
Biomaterials 26:2933-45. 2005..We also uncovered a novel set of genes, which not only validates and logically extends the current model of the pathogenesis of osteolysis and aseptic loosening, but also provides new targets for further research and therapeutics...
Microscopic metallic wear and tissue response in failed titanium hallux metatarsophalangeal implants: two casesNavid Ghalambor
The Hand Care Center, Orange, California, USA
Foot Ankle Int 23:158-62. 2002....
Nitric oxide promotes infectious bone resorption by enhancing cytokine-stimulated interstitial collagenase synthesis in osteoblastsSze-Kwan Lin
Department of Dentistry, National Taiwan University Hospital, Taipei, Taiwan
J Bone Miner Res 18:39-46. 2003..These data suggest that NO derived from macrophages after LPS stimulation may enhance bone loss by augmenting the cytokine-induced MMP-1 production in osteoblasts...
MEK/ERK and signal transducer and activator of transcription signaling pathways modulate oncostatin M-stimulated CCL2 expression in human osteoblasts through a common transcription factorSze Kwan Lin
National Taiwan University Hospital, Taipei, Taiwan
Arthritis Rheum 50:785-93. 2004..To analyze the effects of oncostatin M (OSM), a gp130-type cytokine, on CCL2 expression in MG-63 cells, a human osteosarcoma cell line with a characteristic osteoblastic phenotype, and to investigate the signaling pathway involved...
